Fundraising FoxAMR Action Fund — 2026 Investments
5 investments dated 2026 · listed companies and verified rows first · show all
Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsNCL Technology Ventures Ltd.Boehringer Ingelheim Venture Fund
Trellis is an AI-driven platform that automates advertising, pricing, and profitability optimization for eCommerce sellers on marketplaces like Amazon, Walmart, and Shopify.
AdTechAI & Machine LearningE-commerceOttawa, CA
Denis Leclair(Founder)inFahim Sheikh(Founder)in
Co-investorsOkapi Venture CapitalSentiero VenturesCraft VenturesEaston CapitalNew Science VenturesStout Street Capital
Trellis Health provides personalized health insights that track individual changes over time rather than comparing against population norms.
Digital HealthFemTechHealthtech
Co-investorsNextbluePALETTE VENTURESSwizzle VenturesEaston CapitalNew Science Ventures
Trellis is a fintech company operating in Pakistan that provides financial inclusion solutions and digital transformation services.
Digital HealthFintechImpact & Social GoodPropTechPakistan, PK
Sohail Hasnie(CEO)
Co-investorsGobi PartnersInsitorTPL E VenturesEaston CapitalNew Science Ventures
Trellis Bioscience develops human monoclonal antibody therapeutics targeting bacterial, viral, and cancer indications.
BiotechHealthtechRedwood City, US
Larry Kauvar(Chief Science Officer)Stefan Ryser(President and Chief Executive Officer)inGeoff Dillon(Chief Business Officer)inElisabeth Whitney(Chief Operating Officer)Nora Mende(Chief Financial Officer)
Co-investorsEaston CapitalNew Science Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.